Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects

AIM: To determine the effective dose of glibenclamide by quantifying the dose–response relationship in South African type 2 diabetic patients. PATIENTS AND METHODS: A total of 24 type 2 diabetic patients participated in a glibenclamide dose-escalation study during which glibenclamide, glucose, and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rambiritch, Virendra, Naidoo, Poobalan, Pillai, Goonaseelan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044993/
https://www.ncbi.nlm.nih.gov/pubmed/27713650
http://dx.doi.org/10.2147/CPAA.S102674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044993/
https://www.ncbi.nlm.nih.gov/pubmed/27713650
http://dx.doi.org/10.2147/CPAA.S102674

Ejemplares similares